Section one: Contracting authority
one.1) Name and addresses
Medicines Discovery Catapult
Block 35, Mereside, Alderley Park
Cheshire
SK10 4TG
Contact
Ms Laura Hough
laura.hough@md.catapult.org.uk
Telephone
+44 1625708394
Country
United Kingdom
NUTS code
UK - United Kingdom
Internet address(es)
Main address
Buyer's address
one.2) Information about joint procurement
The contract is awarded by a central purchasing body
one.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at
https://procontract.due-north.com/Advert/Index?advertId=955b7df5-158f-eb11-810c-005056b64545
Additional information can be obtained from the above-mentioned address
Tenders or requests to participate must be submitted electronically via
https://procontract.due-north.com/Advert/Index?advertId=955b7df5-158f-eb11-810c-005056b64545
one.4) Type of the contracting authority
Other type
Research - Drug Discovery
one.5) Main activity
Other activity
Research - Drug Discovery
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
IMPACTT PROJECT- The Supply and Delivery of COVID-19 Samples
Reference number
DN535169
two.1.2) Main CPV code
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.1.3) Type of contract
Supplies
two.1.4) Short description
This Invitation to Tender (ITT) has been issued by MDC for the establishment of a Framework Agreement for IMPACTT PROJECT- The Supply and Delivery of COVID-19 Samples for delivery to Oncimmune.
two.1.5) Estimated total value
Value excluding VAT: £1,100,000
two.1.6) Information about lots
This contract is divided into lots: Yes
Tenders may be submitted for all lots
two.2) Description
two.2.1) Title
Lot 1 Discovery
Lot No
1
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
two.2.4) Description of the procurement
We are looking for appropriate tender responses for the provision of SARS-COV-2 patient samples in order to appoint suppliers onto a Framework Agreement, with the aim of providing clinical samples for immune profiling. The IMPACTT project started 01/10/2020 therefore the SARS-COV-2 samples are required as soon as possible and there is a preference for banked samples which is detailed within the call off criteria section 12 of the ITT. The first set SAR-COV-2 samples are required as soon as possible, no later than 30th June 2021 (unless otherwise agreed by MDC / Oncimmune) to ensure project delivery. Sample requirements are outlined in figure 1 Sample characteristics distribution model within this document. It is anticipated that a maximum of ten (10) suppliers for each lot will be appointed to the framework agreement; however, MDC reserves the right to appoint fewer or more than this number if it is deemed to be in MDC’s best interest.
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.6) Estimated value
Value excluding VAT: £550,000
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
36
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2) Description
two.2.1) Title
Lot 2 Validation
Lot No
2
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
two.2.4) Description of the procurement
We are looking for appropriate tender responses for the provision of SARS-COV-2 patient samples in order to appoint suppliers onto a Framework Agreement, with the aim of providing clinical samples for immune profiling. The IMPACTT project started 01/10/2020 therefore the SARS-COV-2 samples are required as soon as possible and there is a preference for banked samples which is detailed within the call off criteria section 12 of the ITT. The first set SAR-COV-2 samples are required as soon as possible, no later than 30th June 2021 (unless otherwise agreed by MDC / Oncimmune) to ensure project delivery. Sample requirements are outlined in figure 1 Sample characteristics distribution model within this document. It is anticipated that a maximum of ten (10) suppliers for each lot will be appointed to the framework agreement; however, MDC reserves the right to appoint fewer or more than this number if it is deemed to be in MDC’s best interest.
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.6) Estimated value
Value excluding VAT: £550,000
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
36
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Open procedure
Accelerated procedure
Justification:
The Tender is being conducted under the Accelerated Procedure. MDC has determined that a state of urgency exists that renders impracticable the time limit laid down in the PCR. Therefore, the time limit shall be not less than 15 calendar days from the date on which the contract notice is sent. The rationale for this is that MDC have previously advertised within OJEU the tender for The Supply and Delivery of COVID-19 Samples, however unfortunately no suitable bids were submitted. Due to this MDC have reviewed their specification and are now reissuing the tender based on the requirements laid down in the Specification Appendix 3. The Covid-19 Samples are required for an Innovate UK funded project studying the immune profiled of 3000 patients infected with SARS-CoV-2. The project started 01/10/2020 and the samples are required by 30/06/2021 (or a date agreed by MDC / Oncimmune and the awarded Supplier). MDC do not have the time to undertake a full open procedure tendering exercise.
four.1.3) Information about a framework agreement or a dynamic purchasing system
The procurement involves the establishment of a framework agreement
Framework agreement with several operators
In the case of framework agreements, provide justification for any duration exceeding 4 years:
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
four.2) Administrative information
four.2.2) Time limit for receipt of tenders or requests to participate
Date
15 April 2021
Local time
12:00pm
four.2.4) Languages in which tenders or requests to participate may be submitted
English
four.2.6) Minimum time frame during which the tenderer must maintain the tender
Duration in months: 12 (from the date stated for receipt of tender)
four.2.7) Conditions for opening of tenders
Date
15 April 2021
Local time
12:00pm
Section six. Complementary information
six.1) Information about recurrence
This is a recurrent procurement: No
six.4) Procedures for review
six.4.1) Review body
Medicines Discovery Catapult
Block 35, Mereside, Alderley Park
Macclesfield
SK10 4TG
Country
United Kingdom